New Rheumatoid Arthritis Drug Shows Promise in Study
Links shared publicly online about this topic.
- 1,161total visits
New Rheumatoid Arthritis Drug Shows Promise in Study
View full resource at healthcentral.com
Tags: Arthritis, Arthritis Medication, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Drug
Most Recently Shared on May 17, 2010 at 8:32 pm By:
New #RheumatoidArthritis Drug Shows Promise in Study: http://bit.ly/bDhJGj
Cimzia Trial Shows Promise For Axial Spondyloarthritis And Ankylosing Spondylitis
medicalnewstoday.com — “According to UCB, certolizumab pegol achieved top-level results in a phase 3 study, which assessed the drug's efficacy and safety in patients with adult-onset active axial spondyloarthr” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2012 at 5:05 pm By:
Cimzia Trial Shows Promise For Axial Spondyloarthritis And Ankylosing Spondylitis http://t.co/o6piItx0 #healthnews
Drug halts organ damage in inflammatory genetic disorder, study suggests
sciencedaily.com — “A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease. This rare and debilitating genetic disorder causes persistent inflammation and ongoing tissue damage.” View full resource at sciencedaily.com
Most Recently Shared on February 11, 2012 at 6:35 pm By:
Science Daily: Drug halts organ damage in inflammatory genetic disorder, study suggests http://t.co/qLbwP7km Full http://t.co/xwlHZeT9
NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome
medicalnewstoday.com — “A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a ra” View full resource at medicalnewstoday.com
Most Recently Shared on September 6, 2011 at 7:05 am By:
MNT Cervical Cancer Health News
NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome http://mnt.to/3Zqx #cervicalcancer #hpv
Arthritis sufferers' increased risk of heart disease due to disease-related inflammation and other factors, study finds
sciencedaily.com — “Rheumatoid arthritis (RA) sufferers are at an increased risk of dying due to cardiovascular disease. A new five-year study showed that the risk of cardiovascular disease for people with RA is due to disease-related inflammation as well as the risk factors which affect the general population. Treatment of arthritis with disease modifying anti-rheumatic drugs also reduced the patient's risk of heart disease.” View full resource at sciencedaily.com
Most Recently Shared on August 16, 2011 at 10:37 am By:
Arthritis sufferers' increased risk of heart disease due to disease-related inflammation and other factors, stud... http://t.co/CafVEKC
Arthritis sufferers' increased risk of heart disease due to disease-related inflammation and other factors, study finds
sciencedaily.com — “Rheumatoid arthritis (RA) sufferers are at an increased risk of dying due to cardiovascular disease. A new five-year study showed that the risk of cardiovascular disease for people with RA is due to disease-related inflammation as well as the risk factors which affect the general population. Treatment of arthritis with disease modifying anti-rheumatic drugs also reduced the patient's risk of heart disease.” View full resource at sciencedaily.com
Most Recently Shared on August 15, 2011 at 1:19 pm By:
#Arthritis sufferers' > #risk of #heart disease due to inflammation & other factors, study finds: http://t.co/iF9lLcw via @AddThis
Arthritis sufferers' increased risk of heart disease due to disease-related inflammation and other factors, study finds
sciencedaily.com — “Rheumatoid arthritis (RA) sufferers are at an increased risk of dying due to cardiovascular disease. A new five-year study showed that the risk of cardiovascular disease for people with RA is due to disease-related inflammation as well as the risk factors which affect the general population. Treatment of arthritis with disease modifying anti-rheumatic drugs also reduced the patient's risk of heart disease.” View full resource at sciencedaily.com
Most Recently Shared on August 15, 2011 at 3:26 am By:
Arthritis sufferers' increased risk of heart disease due to disease-related inflammation and other factors... http://t.co/VPaMimr
Is Rheumatoid Arthritis Prevention on the Horizon? - New Study Shows Promising Results
spineuniverse.com — “Researchers created a treatment to potentially prevent or reverse rheumatoid arthritis (RA) by imitating a molecule that causes attacking immune cells to self-destruct. The findings may help develop a new class of rheumatoid arthritis medications.” View full resource at spineuniverse.com
Most Recently Shared on July 14, 2011 at 11:27 pm By:
Is Rheumatoid Arthritis Prevention on the Horizon? http://dlvr.it/bCjl0
New RA B-Cell Drug Flops in Early Studies (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The investigational B-cell inhibitor atacicept failed to show clinical efficacy for rheumatoid arthritis in a pair of international phase II trials, researchers reported.” View full resource at qualitypointtech.net
Most Recently Shared on July 5, 2011 at 6:00 pm By:
New RA B-Cell Drug Flops in Early Studies (CME/CE): (MedPage Today) -- The investigational B-cell inhibitor atacic... http://bit.ly/ijGcXZ
Medical News: New RA B-Cell Drug Flops in Early Studies - in Clinical Context, Rheumatoid Arthritis from MedPage Today
medpagetoday.com — “The investigational B-cell inhibitor atacicept failed to show clinical efficacy for rheumatoid arthritis in a pair of international phase II trials, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on July 5, 2011 at 5:43 pm By:
New RA B-Cell Drug Flops in Early Studies (CME/CE) http://bit.ly/kATavZ
Medical News: New RA B-Cell Drug Flops in Early Studies - in Clinical Context, Rheumatoid Arthritis from MedPage Today
medpagetoday.com — “The investigational B-cell inhibitor atacicept failed to show clinical efficacy for rheumatoid arthritis in a pair of international phase II trials, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on July 5, 2011 at 5:36 pm By:
Novel B-cell inhibitor for RA flops in early trials: http://bit.ly/l6kJDy
3 Reasons Why the Public Image of RA Is So Rosy | If you don't have RA, please read | Rheumatoid Arthritis Warrior
rawarrior.com — “As a commenter pointed out on yesterday--™s blog, some studies claim that 50% of RA patients go into remission if they are treated correctly. But we don--™t...” View full resource at rawarrior.com
Most Recently Shared on May 11, 2011 at 1:13 pm By:
@RAWarrior: 3 Reasons Why the Public Image of RA Is So Rosy http://bit.ly/mcvkQu Full http://bit.ly/mjD663
Arthritis drug could help beat melanoma skin cancer, study finds
sciencedaily.com — “A breakthrough discovery promises an effective new treatment for one of the deadliest forms of cancer. Researchers found that leflunomide -- a drug commonly used to treat rheumatoid arthritis -- also inhibits the growth of malignant melanoma.” View full resource at sciencedaily.com
Most Recently Shared on March 24, 2011 at 7:50 am By:
Arthritis drug could help beat melanoma skin cancer, study finds: A breakthrough discovery promises an effective... http://bit.ly/i4selx
Arthritis drug could help beat melanoma skin cancer, study finds
sciencedaily.com — “A breakthrough discovery promises an effective new treatment for one of the deadliest forms of cancer. Researchers found that leflunomide -- a drug commonly used to treat rheumatoid arthritis -- also inhibits the growth of malignant melanoma.” View full resource at sciencedaily.com
Most Recently Shared on March 24, 2011 at 12:10 am By:
Arthritis drug could help beat melanoma skin cancer, study finds: A breakthrough discovery promises an effective... http://bit.ly/gnLp5g
Widely used arthritis pill shows promise against skin cancer
sify.com — “A new study has shown that a widely used arthritis drug could reduce the incidence of non-melanoma skin cancers - the most common cancers in humans. The COX-2 inhibitor celecoxib (also known as...” View full resource at sify.com
Most Recently Shared on December 3, 2010 at 12:26 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
The selective COX-2 inhibitor, celecoxib, reduces the number of nonmelanoma skins cancers in humans by 62%: http://tinyurl.com/33oerdv
Widely used arthritis pill shows promise against skin cancer - World News, 97292
newkerala.com — “Widely used arthritis pill shows promise against skin cancer - Washington, Dec 3 : A new study has shown that a widely used arthritis drug could reduce the incidence of non-melanoma skin cancers - the most common cancers in humans.” View full resource at newkerala.com
Most Recently Shared on December 3, 2010 at 9:04 am By:
Widely used arthritis pill shows promise against skin cancer: Washington, Dec 3 : A new study has shown that a w... http://bit.ly/esH2yX
Advertisement
